Membrane effects of lithium (Li +) and the relationshipof these effects to medical uses ofLi + are currently a subject of much interest. Li § was first used by physiologists as a sodium (Na § substitute when investigating Na+-dependent phenomena (cf. Overton, 1902). More recently the clinical effectiveness of Li + in treating and preventing mania (Schou, 1976) has prompted clinical trials of Li § for depression and other seemingly unrelated conditions such as alcoholism, thymtoxicosis, and tardive dyskinesia (Schou, 1978). However, its usefulness in these other conditions is not yet established. At the cellular level interest has focused on lhembrane transport of Li + and the mechanisms by which Li + alters cell functioning in order to exert its therapeutic effect. That differences in membrane transport may be crucial to Li § therapy was first proposed by Mendels and Frazer (1973) when they found that the erythrocyte-to-plasma Li + concentration" ratio was higher in depressed patients who responded to treatment than in patients who did not respond. This work stimulated several groups to compare Li + flux mechanisms across red blood cell (RBC) membranes of manic-depressive and normal subjects. Although subsequent studies of RBC from manic-depressive patients have questioned the validity of the difference shown by Mendels and Frazer (Carroll, 1977; Kantor etal., 1977;Leckman et al., 1977), several specific defects in transport after initiation of Li § treatment have been identified (cf.